Cytokeratin immunoreactivity in 41 cases of ES/PNET confirmed by molecular diagnostic studies.
Collini
P
P
Sampietro
G
G
Bertulli
R
R
Casali
P G
PG
Luksch
R
R
Mezzelani
A
A
Sozzi
G
G
Pilotti
S
S
D000328:Adult; D014408:Biomarkers, Tumor / Q000032:analysis; D004273:DNA, Neoplasm / Q000032:analysis; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D007633:Keratins / Q000032:analysis / Q000096:biosynthesis / Q000276:immunology*; D008297:Male; D009363:Neoplasm Proteins / Q000032:analysis; D009378:Neoplasms, Multiple Primary / Q000737:chemistry / Q000235:genetics / Q000276:immunology* / Q000473:pathology; D018242:Neuroectodermal Tumors, Primitive / Q000737:chemistry / Q000235:genetics / Q000276:immunology* / Q000473:pathology; D015514:Oncogene Proteins, Fusion / Q000032:analysis; D051789:Proto-Oncogene Protein c-fli-1; D034802:RNA-Binding Protein EWS; D020133:Reverse Transcriptase Polymerase Chain Reaction; D012512:Sarcoma, Ewing / Q000737:chemistry / Q000235:genetics / Q000276:immunology* / Q000473:pathology; D014157:Transcription Factors / Q000032:analysis
D014408:Biomarkers, Tumor; D004273:DNA, Neoplasm; C106031:EWS-FLI fusion protein; D009363:Neoplasm Proteins; D015514:Oncogene Proteins, Fusion; D051789:Proto-Oncogene Protein c-fli-1; D034802:RNA-Binding Protein EWS; D014157:Transcription Factors; D007633:Keratins